Tender For medicines as per annexure a - inj albumin 5% each 2 inj albumin 20% each 3 injj ivig 5gm each 4 inj amoxycillin & potassium clavulanate 1.2gm each 5 inj calcium gluconate 10ml each 6 inj cefoperazine 1000 & sulbactum 500 mg each 7 inj cefoperazone 1gm sulbactum 1gm each 8 |inj cefotaxime 1 gm each 9 injj ceftazidime 1gm each 10 inj ceftazidine 500 mg each 11 inj ceftriaxone 1gm each 12 inj ceftriaxone 500mg 1 each 13 inj cifoperazone 500mg sulbactam 500mg each 14 inj enoxaparin sodium ip 40mg/0.4ml each 15 inj enoxaparin sodium ip 60mg/0.6ml each inj hydroxyethyl starch in isotonic sodium chloride 3%( hestar) 16 each 17 inj htk solution 1000ml each 18 inj htk solution 500ml each 19 inj heparin sodium 25000 iu/5ml each 20 inj isoflurane 50ml each 21 inj isoflurane 100ml each 22 inj erythropoietin 10k 23 inj erythropoietin 2k each 24 inj erythropoietin 4k each 25 inj lohexol 350mg 100 ml each 26 inj isoflurane 250ml each 27 inj labetalol 100mg per 20 mi each 28 inj labetalol 20mg per 4 mi 1 each 29 inj lacosamide 10mg per mi
Tender For e-tender for procurement of drug items under table-a, for two years from the date of aoc. - amoxicillin trihydrate dispersible tabs. i.p 125mg, amoxycillin 250 mg + cloxacillin 250mg capsule., atropine sulphate inj. i.p. 0.6 mg/ml-1ml amp., azacitidine inj 100 mg /vial, azathioprine 50 mg tab., benzyl benzoate application i.p 25% w/w-500 ml bot., bimatoprost eye drop 0.03%, bupivacaine 0.5% inj - 20ml vial, cabergoline tab 0.5mg, caffeine citrate 1 ml inj per vial/amp, carmustine inj. 100mg/vial, cefotaxime sodium inj. i.p. 125 mg.vial., ceftazidime inj. 1gm./vial, cetuximab inj. 100mg( 5mg/ml) / - 20ml vial, cetuximab inj. 500 mg (5mg/ml)/100ml vial, cilostazol tab ip 50 mg, clopidogrel 75mg tab., daclatasvir 60 mg tab., decitabine inj 50 mg, deferasirox 250mg dispersable tab., desflurence inhalation agent 240 ml, dexamethasone 4 mg tab., dexamethasone tab. i.p. 0.5 mg, diclofenac sod. 50 mg tab., diclofenac sodium injection i.p. 25mg/ml- 3ml amps, digoxin tablet i.p. 0.25 mg, dorzolamide hydrochloride 2.0% eye drop in 5ml, fexofenadine tab 120 mg, fibrin sealent with fast & slow setting of thrombin 1ml, fludarabine inj. - 50mg / 5ml, flurourocil inj. i.p. 250mg. in 5ml. amp., fluticasone nasal spray ip 50 mcg (in maximum of 120 mdi pack), furosemide inj. i.p 20mg/2ml. ampoule, halazone tablet for solution u.s.p. 4mg, human hepatitis b immunoglobulin inj. 200 iu volume in 0.5 ml or 1 ml vial/pfs, ibrutinib 140 mg cap., infliximab inj. 100mg/vial, isosorbide-5-mononitrate 20 mg, isosorbide-dinitrate tab i.p. 5mg., ivermectin 6mg tab., leuprolide depot inj. 22.5 mg/vial, levetiracetam inj. 100 mg /ml in 5ml amps, levofloxacin 500 mg tab., levosalbutamol 1.25 mg + ipratropium bromide 500mcg respules, levosalbutamol oral suspension 1mg/5ml, linezolid infusion 600 mg / 300ml, linezolid syrup 100mg / 5ml, melphalan hcl inj. 50 mg (powder), methotrexate tab 15 mg, naproxen 250mg tab., neostigmine methylsulphate inj.i.p. 0.5mg/ ml - 1ml ampoule, nicorandil tabs 5mg, ondansetron inj. 2mg/ ml in 2ml amp., penicillamine 250 mg. cap., plerixafor inj 24mg/1.2ml per vial, polymixin b sulfate inj. 5,00,000 units/vial, pomalidomide 2mg tab / cap, prednisolone tab.20mg., pyrazinamide tab. i.p. 500mg, pyridostigmine tab 30 mg, risperidone tab. 2 mg, sacubitril + valsartan tab. 50mg, sodium chloride inj 0.45% in polypropelene bottle in ffs technology, sodium fusidate cream / ointment 2%, solifenacin 5mg tab., succinylated polygelline, sulfasalazine tab 500 mg, teicoplanin inj. 200 mg /vial, tetanus toxoid inj. (absorbed) 0.5ml amp. single dose, thiamine 100 mg. inj. per 2ml ampule, tinidazole tab ip 500 mg, tropicamide 0.8% with phenylephrine hydrochloride 5% eye drop, valethamate bromide inj 8 mg/ml in 1ml amp., vecuronium bromide inj. 2mg /ml 2ml vial, important note: 1. all prospective bidders are requested to quote the rate in boq as per accounting unit & item specification as mentioned in the table-a. wrong quoting of the rate in boq will be dealt with as per penal provisions of the t&c of the tender.2. tendered quantity is just a tentative quantity and should not be treated as final. it may increase or decrease, as per need of the state. keeping this in mind, the supplier is not allowed to seek termination of the rate contract after finishing supply of tendered quantity.3. quality of the product supplied, may be ascertained by testing / physical examination by the experts at any stage of the tender period.4. the prospective bidders of the said tender are requested to make a declaration in affidavit under annexure vi(b) in case of sole manufacturer/importer (i.e. proprietary in nature).5. if the item(s) under sole manufacturer / importer is (are) proprietary in nature, quarterly intimation is solicited from the approved bidders positively regarding the status of their item(s) proprietary in nature, otherwise their item(s) will be blocked in the smis.6. in case of tie bid, decision will be taken by the tia as per g.o. no. 2320-f